Medicus Pharma Celebrates Nasdaq Anniversary with Opening Bell Ceremony
ByAinvest
Friday, Jan 23, 2026 1:26 pm ET1min read
MDCX--
Medicus Pharma, a biotech company, celebrated its one-year anniversary on the Nasdaq exchange with an opening bell ceremony. The company's CEO, Dr. Raza Bokhari, highlighted the milestone as a reflection of Medicus' progress and focus on advancing its clinical portfolio. Medicus' pipeline includes SkinJect for basal cell carcinoma and Teverelix for prostate cancer, with an estimated combined market opportunity of $6 billion. The company also announced a reduced royalty rate for Teverelix, making it more attractive for future partnering.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet